Slatina K I, Druzhinina G Iu
Zh Mikrobiol Epidemiol Immunobiol. 1986 Oct(10):43-6.
The effectiveness of mass immunization against mumps is evaluated with the use of data on 20 cities in the European part of the RSFSR. The expediency of using the indicator data on morbidity for many years in the preimmunization period for such evaluation is shown. These data permit the evaluation of the effectiveness of immunization for any month in the course of its carrying out. An essential decrease in mumps morbidity has been found to occur if immunization covered not less than 15-30% of children aged 1-14 years.
